CNR1 and obesity due to melanocortin 4 receptor deficiency: Several drugs are recommended in the pharmacological approach and in the last years the cannabinoid-1 receptor blocker rimonabant has been proposed as a potential effective therapeutic approach in the management of obesity [5].